Resource data sheet
Prev.
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pRx hCD25iN

Retroviral vector of human CD25

Catalog number RDB01700
Resource name pRx hCD25iN
Alternative name Rx-hCD25-IRES-Neo
Clone info. Retroviral vector of human CD25. ires, neo
Vector backbone pRxZiN (Plasmid)
Selectable markers Amp^r (E. coli), Neo^r (mammalian cell)
Gene/insert name Human CD25/IL-2 receptor cDNA
Depositor|Developer Hamada, Hirofumi |
Other clones in our bank

External Database
Human CD25/IL-2 receptor

          Reference sequence
            
           
          Remarks, protocol and/or map (gif) RDB01700.gif

          Distribution information

          Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
          Terms and conditions for distribution The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested.(J. Leukoc. Biol., 60, 181-190 (1996).) In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
          Ordering
          Order form [Credit Card Payment]  [Bank Transfer Payment]
          Material Transfer Agreement (MTA for use for not-for-profit academic purpose) [Word]
          Please visit Information of Request for Distribution.[link] 
          Remarks Remember that you will be working with samples containing infectious virus.
          提供案内 (日本国内) [open/close]

          提供条件 非営利機関の非営利学術研究へ提供する。利用者が本件リソースを利用した研究成果に基づき特許申請、商業活動等を行う場合は、利用者は事前に寄託者に連絡する。利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する(J. Leukoc. Biol., 60, 181-190 (1996).)。利用者は、研究成果の公表にあたって謝辞の表明を必要とする。
          提供依頼
          提供依頼書 [Word]
          提供同意書 (MTA、非営利機関による非営利学術研究用)[Word]
          手続きの概要は、「提供申込みについて[link]」をご覧ください。
          備考 このリソースはウイルス粒子産生用のため、取扱いに注意が必要です。

          Catalog # Resource name Shipping form Fee (non-profit org.)
          RDB01700 pRx hCD25iN DNA solution Please contact us.

          Please review the QC test results indicated by check icon below as well as clone information before placing your order.

          How to cite this biological resource

          Materials & Methods section:

          The pRx hCD25iN was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB01700).

          Reference section:

          Further references such as user reports and related articles (go to bottom)


          Tips

          Featured content


          QC test results

          RIKEN BRC has sequenced portions of this material for quality test.
          Please review the QC test results indicated by check icon as well as clone information before placing your order.

          Test sheet RDB13005_A4Jv.pdf check

          Nucleotide sequence of a portion of this resource (if available).

          Primer: T7_20bp
          Sequence file: RDB13005_A4Jva.seq check
          >01700_13005_A4Jv_2_T7_20bp_E12_15.ab1
              1 CTCGTCTGGA GATGGATTCA TACCTGCTGA TGTGGGGACT GCTCACGTTC ATCATGGTGC
             61 CTGGCTGCCA GGCAGAGCTC TGTGACGATG ACCCGCCAGA GATCCCACAC GCCACATTCA
            121 AAGCCATGGC CTACAAGGAA GGAACCATGT TGAACTGTGA ATGCAAGAGA GGTTTCCGCA
            181 GAATAAAAAG CGGGTCACTC TATATGCTCT GTACAGGAAA CTCTAGCCAC TCGTCCTGGG
            241 ACAACCAATG TCAATGCACA AGCTCTGCCA CTCGGAACAC AATGAAACAA GTGACACCTC
            301 AACCTGAAGA ACAGAAAGAA AGGAAAACCA CAGAAATGCA AAGTCCAATG CAGCCAGTGG
            361 ACCAAGCGAG CCTTCCAGGT CACTGCAGGG AACCTCCACC ATGGGAAAAT GAAGCCACAG
            421 AGAGAATTTA TCATTTCGTG GTGGGGCAGA TGGTTTATTA TCAGTGCGTC CAGGGATACA
            481 GGGCTCTACA CAGAGGTCCT GCTGAGAGCG TCTGCAAAAT GACCCACGGG AAGACAAGGT
            541 GGACCCAGCC CCAGCTCATA TGCACAGGTG AAATGGAGAC CAGTCAGTTT CCAGGTGAAG
            601 AGAAGCCTCA GGCAAGCCCC GAAGGCCGTC CTGAGAGTGA GACTTCCTGC CTCGTCACAA
            661 CAACAGATTT TCAAATACAG ACAGAAATGG CTGCAACCAT GGAGACGTCC ATATTTACAA
            721 CAGAGTACCA GGTAGCAGTG GCCGGCTGTG TTTTCCTGCT GATCAGCGTC CTCCTCCTGA
            781 GTGGGCTCAC CTGGCAGCGG AGACAGAGGA AGAGTAGAAG AACAATCTAG CCAGCACAAT
            841 GGCGGCCGCA GTATTCTATA GTGTCACAAT GGATCCTCTA GAGAATTCCG CCCCCCCCTA
          901 CCCCCCCTTC ACCC
          //
          Primer: IRES-F
          Sequence file: RDB13005_A4Jvb.seq check
          >01700_13005_A4Jv_2_IRES-F_F12_18.ab1
              1 GCATCTCTGT GTTTAGTCGA GGTTAAAAAA CGTCTAGGCC CCCCGAACCA CGGGGACGTG
             61 GTTTTCCTTT GAAAAACACG ATGATAAGCT TGCCACAACC ATGGGGATCG GCCATTGAAC
            121 AAGATGGATT GCACGCAGGT TCTCCGGCCG CTTGGGTGGA GAGGCTATTC GGCTATGACT
            181 GGGCACAACA GACAATCGGC TGCTCTGATG CCGCCGTGTT CCGGCTGTCA GCGCAGGGGC
            241 GCCCGGTTCT TTTTGTCAAG ACCGACCTGT CCGGTGCCCT GAATGAACTG CAGGACGAGG
            301 CAGCGCGGCT ATCGTGGCTG GCCACGACGG GCGTTCCTTG CGCAGCTGTG CTCGACGTTG
            361 TCACTGAAGC GGGAAGGGAC TGGCTGCTAT TGGGCGAAGT GCCGGGGCAG GATCTCCTGT
            421 CATCTCACCT TGCTCCTGCC GAGAAAGTAT CCATCATGGC TGATGCAATG CGGCGGCTGC
            481 ATACGCTTGA TCCGGCTACC TGCCCATTCG ACCACCAAGC GAAACATCGC ATCGAGCGAG
            541 CACGTACTCG GATGGAAAGC CGGTCTTGTC GATCAGGATG ATCTGGACGA AGAGCATCAG
            601 GGGCTCGCGC CAGCCGAACT GTTCGCCAGG CTCAAGGCGC GCATGCCCGA CGGCGAGGAT
            661 CTCGTCGTGA CCCATGGCGA TGCCTGCTTG CCGAATATCA TGGTGGAAAA TGGCCGCTTT
            721 TCTGGATTCA TCGACTGTGG CCGGCTGGGT GTGGCGGACC GCTATCAGGA CATAGCGTTG
            781 GCTACCCGTG ATATTGCTGA AGAGCTTGGC GGCGAATGGG CTGACCGCTT CCTCGTGCTT
            841 TACGGTATCG CCGCTCCCGA TTCGCAGCGC ATCGCCTTCT ATCGCCTTCT TGACGAGTTC
            901 TTCTGAGGGA TCCGGAGCCA TAGATAAAAT AAAAGATTTT ATTTAGTCTC CAGAAAAAGG
            961 GGGGAATGAA AGACCCCACC TGTAGGTTTG GCAAGCTAGC TTAAGTAACG CCATTTTGCA
           1021 AGGCATGGAA AAATACATAA ACTGAGATAG AGAAGTTTCA GATCAAGGTC AGACAGATGG
           1081 GAACAGCTGA ATATGGGTAA ACAGATATCT GTGGTAAGCA GGTTCCTTGA CCCCCCGGGC
          1141 TTCAAGGCCA
          //

          Please visit Sequencing and PCR primers for primer information.


          References

          Original, user report and related articles

          reference Wakimoto, H., Efficient retrovirus-mediated cytokine-gene transduction of primary-cultured human glioma cells for tumor vaccination therapy. Jpn. J. Cancer Res., 88, 296-305 (1997). PMID 9140115.

          2023.08.18

          GNP_filter3_RDBDEP_html_230702.pl